Correlation Between HLS Therapeutics and Integrated Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Integrated Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Integrated Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Integrated Cannabis Solutions, you can compare the effects of market volatilities on HLS Therapeutics and Integrated Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Integrated Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Integrated Cannabis.

Diversification Opportunities for HLS Therapeutics and Integrated Cannabis

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between HLS and Integrated is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Integrated Cannabis Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Cannabis and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Integrated Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Cannabis has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Integrated Cannabis go up and down completely randomly.

Pair Corralation between HLS Therapeutics and Integrated Cannabis

Assuming the 90 days horizon HLS Therapeutics is expected to under-perform the Integrated Cannabis. But the pink sheet apears to be less risky and, when comparing its historical volatility, HLS Therapeutics is 4.02 times less risky than Integrated Cannabis. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Integrated Cannabis Solutions is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.05  in Integrated Cannabis Solutions on August 26, 2024 and sell it today you would earn a total of  0.32  from holding Integrated Cannabis Solutions or generate 640.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HLS Therapeutics  vs.  Integrated Cannabis Solutions

 Performance 
       Timeline  
HLS Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Integrated Cannabis 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Integrated Cannabis Solutions are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, Integrated Cannabis disclosed solid returns over the last few months and may actually be approaching a breakup point.

HLS Therapeutics and Integrated Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HLS Therapeutics and Integrated Cannabis

The main advantage of trading using opposite HLS Therapeutics and Integrated Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Integrated Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Cannabis will offset losses from the drop in Integrated Cannabis' long position.
The idea behind HLS Therapeutics and Integrated Cannabis Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets